Celldex Therapeutics News and Activities

Presence

Celldex Therapeutics develops antibody-based medicines for inflammatory diseases and cancer. It provides drug research and clinical development programs for patients, healthcare providers, and pharmaceutical partners.

Celldex Therapeutics products and services overview:

Antibody therapies
Cancer immunotherapy
Inflammation treatments
Drug discovery
Clinical development

Revenue: ~$2 million

Employees: 160

Headquarters: Hampton, United States (USA)

Celldex Therapeutics is one of the...

Celldex Therapeutics is a company listed under the stock ticker CLDX (US).

Executives

View the org chart displaying its 40 main executives

Most searched biographies at Celldex Therapeutics

Popular executive movements at Celldex Therapeutics

Richard Wright, Senior Vice President and Chief Commercial Officer, is retiring (posted on November 11 2025).
Teri Lawver has joined the company as Senior Vice President, Chief Commercial Officer (posted on November 11 2025).

Create your alert
to follow the executive moves at Celldex Therapeutics.